Sort
8,912 grants matching “sars cov 2”
Biological Sequence Quality Control and Organization
$259,065Eric Nawrocki · National Library Of Medicine · ZIB · FY2025 · LM
The role of adipocyte-driven inflammation and leptin pathway in pulmonary viral infections caused by SARS-CoV-2 and influenza A viruses
$259,000Mariano Carossino · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM
Reagents to Chemically Tag Specific Coronavirus Spike Proteins
$258,854Steven A Benner · Firebird Biomolecular Sciences, Llc · R43 · FY2021 · AI
Antiviral T cell Responses During SARS-CoV-2 Infection
$258,827Heather Hickman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
DNA-based assay for calorimetric determination and quantitation of protein concentrations in pure or mixed solutions
$258,625Matthew Walter Eskew · Thermocap Laboratories Inc. · R43 · FY2022 · GM
Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation
$258,129Chen-Hsiang Shen · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Synthetic Scavenger Medical Countermeasures for Fentanyl
$258,060Xiaohe Liu · Sri International · R21 · FY2024 · DA
The role of adipocyte-drive inflammation and leptin pathway in pulmonary viral infections caused by SARS-CoV-2 and influenza A viruses
$257,822Mariano Carossino · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2025 · GM
Rewiring SARS-CoV Genome Organization and Pathogenesis
$257,344Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2008 · AI
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1
$257,283Anna-Lena Steckelberg · Columbia University Health Sciences · R21 · FY2022 · AI
Clinical Studies Of Abnormal Host Defense
$257,105John I Gallin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Sypmtoms in Adults
$257,101Barbara J Polivka · University Of Kansas Medical Center · R21 · FY2021 · ES
An Innovative Approach to Improving Asthma Control for World Trade Center Rescue and Recovery Workers through Telehealth Enriched Asthma Management (WTC-TEAM)
$257,074Erin Thanik · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · OH
Pre-clinical assessment of JAK inhibitors to ameliorate cytokine storms in Down syndrome
$257,044Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2020 · AI
Tobacco-based Sustainable Squalene for Novel Vaccine Adjuvant Emulsions
$257,003Connor R. Gorman · Synshark Llc · R43 · FY2022 · AI
Adjuvant testing pipeline for recombinant SARS-CoV2 vaccines
$257,000Ofer Levy · Boston Children'S Hospital · N01 · FY2021 · AI
How S. aureus protein SSL11 inhibits neutrophil migration
$256,924Chen Chen · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM
The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 Replication and Pathogenesis
$256,790Ricardo Rajsbaum · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Universal affinity membrane chromatography for rapid, one-step purification of proteins
$256,576Scott M Husson · Trialtus Bioscience, Llc · R41 · FY2021 · GM
Improving influenza vaccines through wastewater-based macro-scale strain surveillance
$256,575Sarah Jo Kane · Gt Molecular, Llc · R43 · FY2022 · AI
Novel antibody polymer reagents for SARS-CoV-2 detection
$256,506Lovick Edward Cannon · Novab, Inc. · R43 · FY2021 · AI
Role of Secretoglobin 1A1 Protein in COVID-19-induced Thrombosis
$256,467Aprile L Pilon · Apcbio Innovations, Inc. · R43 · FY2021 · HL
Clinical Core
$256,393R. Sharon Chinthrajah · Stanford University · U19 · FY2025 · AI
Protective film-forming disinfectant based on chitosan/water/ethanol tertiary solutions
$256,321Alexey A Vertegel · Vrm Labs Inc · R41 · FY2021 · AI
Development of rapid, low-cost, and high throughput COVID-19 antibody assays
$256,131Maung K Khaing Oo · Optofluidic Bioassay Llc · R43 · FY2022 · GH